PMDA drug package insert
プロペシア錠0.2mg
PMDA Prescription drug · オルガノン株式会社 · package insert Aug 29, 2023
Key facts
| Brand names | プロペシア錠0.2mg, プロペシア錠1mg |
|---|---|
| Nonproprietary names | フィナステリド |
| Companies | 製造販売元／オルガノン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 5α－還元酵素Ⅱ型阻害薬; ◎男性型脱毛症用薬◎ |
| Therapeutic category codes | 872499 |
| YJ codes | 249900XF1021, 249900XF2028 |
| Approval numbers | 21700AMY00237000, 21700AMY00236000 |
| Package insert edition | 第4版 |
| Package insert date | Aug 29, 2023 |
| PMDA document key | 181615_249900XF1021_3 |
| PMDA company code | 181615 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: